DCF — METROWEST MEDICAL CENTER
Enterprise Value: $-366.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-366.9M
Enterprise Value
$-115.6M
PV of Cash Flows
$-251.3M
PV of Terminal Value
$-404.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $214.6M | $-23.1M | -11.0% | $-32.2M | $-29.3M |
| Year 2 | $221.0M | $-21.6M | -10.0% | $-31.0M | $-25.6M |
| Year 3 | $227.7M | $-20.0M | -9.0% | $-29.6M | $-22.3M |
| Year 4 | $234.5M | $-19.4M | -8.0% | $-29.3M | $-20.0M |
| Year 5 | $241.5M | $-19.4M | -8.0% | $-29.6M | $-18.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-366.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$208.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11279674342235464
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5